-
- Kurebayashi Junichi
- Department of Breast and Thyroid Surgery, Kawasaki Medical School.
書誌事項
- 公開日
- 2007
- DOI
-
- 10.2325/jbcs.954
- 公開者
- 日本乳癌学会
この論文をさがす
説明
Breast cancer is a hormone-dependent cancer like prostate cancer and endometrial cancer. Estrogen plays important roles in the development and progression of breast cancer. Endocrine therapy is the treatment of choice for estrogen receptor- and/or progesterone receptor-positive breast cancer. Endocrine therapy has been used for several purposes, including chemoprevention, preoperative treatment, postoperative adjuvant treatment and treatment for recurrent diseases. A large number of clinical trials have provided evidence showing the clinical benefits of various endocrine therapies for the treatment of breast cancer. The current status and recent advances in endocrine therapy for breast cancer are reviewed based on the results of current clinical trials. Future perspectives of endocrine therapy are also discussed.
収録刊行物
-
- Breast Cancer
-
Breast Cancer 14 (2), 200-214, 2007
日本乳癌学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679457281152
-
- NII論文ID
- 130004467483
- 10019480868
-
- NII書誌ID
- AA1103354X
-
- DOI
- 10.2325/jbcs.954
-
- ISSN
- 18804233
- 13406868
-
- PubMed
- 17485907
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可

